At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ELAB Elevai Labs, Inc.
Market Closed 12-20 16:00:00 EST
2.56
+0.21
+8.94%
盘后2.53
-0.03-1.17%
19:59 EST
High2.70
Low2.08
Vol1.26M
Open2.57
D1 Closing2.35
Amplitude26.38%
Mkt Cap7.87M
Tradable Cap7.74M
Total Shares3.07M
T/O3.09M
T/O Rate41.79%
Tradable Shares3.02M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada
ELEVAI Biosciences, a Subsidiary of ELEVAI Labs Inc., Announces FDA Regulatory Pathway for El-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.